

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.95036082 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.78943093 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.55984686 |
| 4 | negative regulation of cell killing (GO:0031342) | 5.38125381 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.38125381 |
| 6 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.17524852 |
| 7 | cellular response to type I interferon (GO:0071357) | 4.21680155 |
| 8 | type I interferon signaling pathway (GO:0060337) | 4.21680155 |
| 9 | response to type I interferon (GO:0034340) | 4.16484843 |
| 10 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.16256516 |
| 11 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.12459136 |
| 12 | response to interferon-beta (GO:0035456) | 4.09019957 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.05779156 |
| 14 | immunoglobulin mediated immune response (GO:0016064) | 3.90856994 |
| 15 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.83478611 |
| 16 | NIK/NF-kappaB signaling (GO:0038061) | 3.69360673 |
| 17 | regulation of chronic inflammatory response (GO:0002676) | 3.66887497 |
| 18 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.61978826 |
| 19 | regulation of T cell tolerance induction (GO:0002664) | 3.57418792 |
| 20 | positive regulation of defense response to virus by host (GO:0002230) | 3.55559668 |
| 21 | regulation of regulatory T cell differentiation (GO:0045589) | 3.51963931 |
| 22 | positive regulation of antigen processing and presentation (GO:0002579) | 3.50277988 |
| 23 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.49426048 |
| 24 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.47942192 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.47444346 |
| 26 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.42178828 |
| 27 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.30469721 |
| 28 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.29941878 |
| 29 | detection of bacterium (GO:0016045) | 3.28598969 |
| 30 | regulation of antigen processing and presentation (GO:0002577) | 3.25486085 |
| 31 | negative regulation of viral genome replication (GO:0045071) | 3.20135344 |
| 32 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.17595773 |
| 33 | regulation of cell killing (GO:0031341) | 3.16241244 |
| 34 | cellular response to interleukin-15 (GO:0071350) | 3.15783569 |
| 35 | regulation of cellular extravasation (GO:0002691) | 3.14659129 |
| 36 | regulation of tolerance induction (GO:0002643) | 3.14422979 |
| 37 | response to interleukin-15 (GO:0070672) | 3.12869509 |
| 38 | detection of other organism (GO:0098543) | 3.10269220 |
| 39 | positive regulation of tolerance induction (GO:0002645) | 3.09341473 |
| 40 | regulation of gamma-delta T cell activation (GO:0046643) | 3.06708297 |
| 41 | cytidine deamination (GO:0009972) | 3.03421447 |
| 42 | cytidine metabolic process (GO:0046087) | 3.03421447 |
| 43 | cytidine catabolic process (GO:0006216) | 3.03421447 |
| 44 | B cell mediated immunity (GO:0019724) | 3.03414515 |
| 45 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.00454566 |
| 46 | positive regulation of cell killing (GO:0031343) | 2.97761589 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 2.96375419 |
| 48 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.96235826 |
| 49 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.96235826 |
| 50 | positive regulation of T cell mediated immunity (GO:0002711) | 2.95417069 |
| 51 | cellular response to interferon-beta (GO:0035458) | 2.94717895 |
| 52 | negative T cell selection (GO:0043383) | 2.90500423 |
| 53 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.90445176 |
| 54 | lymph node development (GO:0048535) | 2.90062777 |
| 55 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.89768189 |
| 56 | regulation of T cell mediated immunity (GO:0002709) | 2.88872894 |
| 57 | myeloid dendritic cell differentiation (GO:0043011) | 2.88609653 |
| 58 | T-helper 1 type immune response (GO:0042088) | 2.88278482 |
| 59 | negative thymic T cell selection (GO:0045060) | 2.87860348 |
| 60 | regulation of defense response to virus by host (GO:0050691) | 2.87575745 |
| 61 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.87142779 |
| 62 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.85661274 |
| 63 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.84500672 |
| 64 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.83881668 |
| 65 | defense response to protozoan (GO:0042832) | 2.83708598 |
| 66 | positive regulation of interleukin-17 production (GO:0032740) | 2.83279202 |
| 67 | negative regulation of T cell mediated immunity (GO:0002710) | 2.80556711 |
| 68 | interferon-gamma secretion (GO:0072643) | 2.80171000 |
| 69 | positive thymic T cell selection (GO:0045059) | 2.77204209 |
| 70 | negative regulation of innate immune response (GO:0045824) | 2.76953813 |
| 71 | cellular response to interferon-gamma (GO:0071346) | 2.76444647 |
| 72 | regulation of interferon-alpha production (GO:0032647) | 2.76335292 |
| 73 | response to interferon-alpha (GO:0035455) | 2.74527562 |
| 74 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.73386736 |
| 75 | cytokine biosynthetic process (GO:0042089) | 2.72866041 |
| 76 | response to interferon-gamma (GO:0034341) | 2.71492253 |
| 77 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.69621583 |
| 78 | leukocyte aggregation (GO:0070486) | 2.68129891 |
| 79 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.67125116 |
| 80 | myeloid dendritic cell activation (GO:0001773) | 2.66069723 |
| 81 | positive regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.65602433 |
| 82 | positive regulation of isotype switching (GO:0045830) | 2.64367506 |
| 83 | response to protozoan (GO:0001562) | 2.62926585 |
| 84 | regulation of interleukin-12 production (GO:0032655) | 2.62924812 |
| 85 | positive regulation of interferon-alpha production (GO:0032727) | 2.62876659 |
| 86 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.62793717 |
| 87 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.62723161 |
| 88 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.62286903 |
| 89 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.61979031 |
| 90 | regulation of memory T cell differentiation (GO:0043380) | 2.61641931 |
| 91 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.61534577 |
| 92 | germinal center formation (GO:0002467) | 2.61227936 |
| 93 | mast cell activation (GO:0045576) | 2.60432124 |
| 94 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.60129578 |
| 95 | regulation of T-helper 1 type immune response (GO:0002825) | 2.59652538 |
| 96 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.59223622 |
| 97 | mature B cell differentiation involved in immune response (GO:0002313) | 2.58194886 |
| 98 | positive regulation of adaptive immune response (GO:0002821) | 2.55953595 |
| 99 | lymphocyte chemotaxis (GO:0048247) | 2.55789164 |
| 100 | positive regulation of interferon-gamma production (GO:0032729) | 2.54927638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.79461818 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.85249184 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.76794701 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.80106420 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.58172772 |
| 6 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.58056226 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.35892054 |
| 8 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.88794770 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.75598598 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.38423787 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.35703165 |
| 12 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.33429037 |
| 13 | MYB_26560356_Chip-Seq_TH2_Human | 2.33411319 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.30975644 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.26594742 |
| 16 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.12584158 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.11221607 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.08616779 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.04095538 |
| 20 | MAF_26560356_Chip-Seq_TH1_Human | 1.92950892 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.92080771 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.90286382 |
| 23 | MYB_26560356_Chip-Seq_TH1_Human | 1.85611356 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84157328 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.78805052 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78221566 |
| 27 | UTX_26944678_Chip-Seq_JUKART_Human | 1.70765538 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.70094565 |
| 29 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65076893 |
| 30 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.63941584 |
| 31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.63576930 |
| 32 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.60847369 |
| 33 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58796268 |
| 34 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58137377 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57061397 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.54477291 |
| 37 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52041931 |
| 38 | GATA3_26560356_Chip-Seq_TH2_Human | 1.49748981 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.49235383 |
| 40 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.48950701 |
| 41 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47670432 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46315393 |
| 43 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.43424571 |
| 44 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.42487388 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.36549625 |
| 46 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32328512 |
| 47 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31078133 |
| 48 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.26080293 |
| 49 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25505731 |
| 50 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25247596 |
| 51 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24768203 |
| 52 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.20586007 |
| 53 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20273672 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.20145144 |
| 55 | P300_27268052_Chip-Seq_Bcells_Human | 1.19537939 |
| 56 | MYC_22102868_ChIP-Seq_BL_Human | 1.18317976 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17802633 |
| 58 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.17388334 |
| 59 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.15657537 |
| 60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.15135808 |
| 61 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14891873 |
| 62 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14140728 |
| 63 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.11569373 |
| 64 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.10926359 |
| 65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10554044 |
| 66 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.08119217 |
| 67 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07164930 |
| 68 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06675368 |
| 69 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.06547458 |
| 70 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.05762457 |
| 71 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01590165 |
| 72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.01270973 |
| 73 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00924285 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00778797 |
| 75 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.99162114 |
| 76 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.98533197 |
| 77 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97883551 |
| 78 | SA1_27219007_Chip-Seq_Bcells_Human | 0.97194147 |
| 79 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.97189120 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96608121 |
| 81 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.96174603 |
| 82 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.95745421 |
| 83 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95379259 |
| 84 | P68_20966046_ChIP-Seq_HELA_Human | 0.94783884 |
| 85 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94333847 |
| 86 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91466125 |
| 87 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90936077 |
| 88 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.90747403 |
| 89 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90543614 |
| 90 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.89748275 |
| 91 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.87912477 |
| 92 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.87891907 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.87666536 |
| 94 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.87180084 |
| 95 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.84708258 |
| 96 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.83420394 |
| 97 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.83188343 |
| 98 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.80643927 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.80555119 |
| 100 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.80379510 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.10554012 |
| 2 | MP0003436_decreased_susceptibility_to | 3.90304238 |
| 3 | MP0005671_abnormal_response_to | 3.47102933 |
| 4 | MP0009785_altered_susceptibility_to | 3.42098862 |
| 5 | MP0003724_increased_susceptibility_to | 3.30569588 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.14701298 |
| 7 | MP0005387_immune_system_phenotype | 3.11467895 |
| 8 | MP0001790_abnormal_immune_system | 3.11467895 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.97677094 |
| 10 | MP0000685_abnormal_immune_system | 2.94683897 |
| 11 | MP0003303_peritoneal_inflammation | 2.85011153 |
| 12 | MP0005025_abnormal_response_to | 2.74111182 |
| 13 | MP0001800_abnormal_humoral_immune | 2.72931782 |
| 14 | MP0010155_abnormal_intestine_physiology | 2.71490515 |
| 15 | MP0006082_CNS_inflammation | 2.69711629 |
| 16 | MP0002723_abnormal_immune_serum | 2.54001303 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.40014416 |
| 18 | MP0002419_abnormal_innate_immunity | 2.34754535 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.34378633 |
| 20 | MP0002420_abnormal_adaptive_immunity | 2.26609500 |
| 21 | MP0001819_abnormal_immune_cell | 2.26125118 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.20989807 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.11033943 |
| 24 | MP0001845_abnormal_inflammatory_respons | 1.94974148 |
| 25 | MP0009840_abnormal_foam_cell | 1.91995754 |
| 26 | MP0002405_respiratory_system_inflammati | 1.86899678 |
| 27 | MP0009764_decreased_sensitivity_to | 1.83018127 |
| 28 | MP0005360_urolithiasis | 1.81101922 |
| 29 | MP0001873_stomach_inflammation | 1.79100858 |
| 30 | MP0004947_skin_inflammation | 1.78331056 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.77943556 |
| 32 | MP0000716_abnormal_immune_system | 1.71654514 |
| 33 | MP0003191_abnormal_cellular_cholesterol | 1.69050191 |
| 34 | MP0003866_abnormal_defecation | 1.67641533 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.64784319 |
| 36 | MP0004510_myositis | 1.64072915 |
| 37 | MP0002398_abnormal_bone_marrow | 1.63753741 |
| 38 | MP0008469_abnormal_protein_level | 1.62315612 |
| 39 | MP0005058_abnormal_lysosome_morphology | 1.61409272 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.56294316 |
| 41 | MP0003300_gastrointestinal_ulcer | 1.51896146 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.45807863 |
| 43 | MP0005083_abnormal_biliary_tract | 1.44148867 |
| 44 | MP0002166_altered_tumor_susceptibility | 1.42946782 |
| 45 | MP0000858_altered_metastatic_potential | 1.42192206 |
| 46 | MP0002722_abnormal_immune_system | 1.40227329 |
| 47 | MP0005365_abnormal_bile_salt | 1.40092519 |
| 48 | MP0002139_abnormal_hepatobiliary_system | 1.39975970 |
| 49 | MP0003075_altered_response_to | 1.38138933 |
| 50 | MP0002429_abnormal_blood_cell | 1.37584440 |
| 51 | MP0002006_tumorigenesis | 1.35110903 |
| 52 | MP0001853_heart_inflammation | 1.32809520 |
| 53 | MP0002933_joint_inflammation | 1.29874111 |
| 54 | MP0005166_decreased_susceptibility_to | 1.26399686 |
| 55 | MP0005085_abnormal_gallbladder_physiolo | 1.22096126 |
| 56 | MP0005310_abnormal_salivary_gland | 1.17258461 |
| 57 | MP0002998_abnormal_bone_remodeling | 1.16393020 |
| 58 | MP0005451_abnormal_body_composition | 1.14986763 |
| 59 | MP0000703_abnormal_thymus_morphology | 1.13549084 |
| 60 | MP0009278_abnormal_bone_marrow | 1.11087524 |
| 61 | MP0000343_altered_response_to | 1.10412473 |
| 62 | MP0003011_delayed_dark_adaptation | 1.10278889 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.08068325 |
| 64 | MP0005165_increased_susceptibility_to | 1.07610994 |
| 65 | MP0001663_abnormal_digestive_system | 1.07087613 |
| 66 | MP0001501_abnormal_sleep_pattern | 1.03362016 |
| 67 | MP0009763_increased_sensitivity_to | 0.95839696 |
| 68 | MP0005390_skeleton_phenotype | 0.94504166 |
| 69 | MP0001764_abnormal_homeostasis | 0.93299428 |
| 70 | MP0005167_abnormal_blood-brain_barrier | 0.91199384 |
| 71 | MP0000490_abnormal_crypts_of | 0.90933460 |
| 72 | MP0002254_reproductive_system_inflammat | 0.90415172 |
| 73 | MP0002132_abnormal_respiratory_system | 0.88008741 |
| 74 | MP0005084_abnormal_gallbladder_morpholo | 0.87225331 |
| 75 | MP0002876_abnormal_thyroid_physiology | 0.84092810 |
| 76 | MP0003172_abnormal_lysosome_physiology | 0.83581941 |
| 77 | MP0003448_altered_tumor_morphology | 0.82872460 |
| 78 | MP0000249_abnormal_blood_vessel | 0.82123571 |
| 79 | MP0000604_amyloidosis | 0.80558665 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.78165146 |
| 81 | MP0001545_abnormal_hematopoietic_system | 0.77714747 |
| 82 | MP0005397_hematopoietic_system_phenotyp | 0.77714747 |
| 83 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74903310 |
| 84 | MP0003183_abnormal_peptide_metabolism | 0.74600524 |
| 85 | MP0009643_abnormal_urine_homeostasis | 0.74464362 |
| 86 | MP0001666_abnormal_nutrient_absorption | 0.73590382 |
| 87 | MP0002277_abnormal_respiratory_mucosa | 0.72769088 |
| 88 | MP0002693_abnormal_pancreas_physiology | 0.71023576 |
| 89 | MP0002136_abnormal_kidney_physiology | 0.70116631 |
| 90 | MP0005381_digestive/alimentary_phenotyp | 0.64545049 |
| 91 | MP0000609_abnormal_liver_physiology | 0.64400572 |
| 92 | MP0001765_abnormal_ion_homeostasis | 0.63896006 |
| 93 | MP0005164_abnormal_response_to | 0.63116240 |
| 94 | MP0005319_abnormal_enzyme/_coenzyme | 0.62634537 |
| 95 | MP0009765_abnormal_xenobiotic_induced | 0.62454881 |
| 96 | MP0005410_abnormal_fertilization | 0.60652975 |
| 97 | MP0004147_increased_porphyrin_level | 0.59496525 |
| 98 | MP0003045_fibrosis | 0.58780225 |
| 99 | MP0003795_abnormal_bone_structure | 0.58178498 |
| 100 | MP0002019_abnormal_tumor_incidence | 0.57361385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.85598808 |
| 2 | Myositis (HP:0100614) | 4.50038745 |
| 3 | Orchitis (HP:0100796) | 4.26771630 |
| 4 | Retrobulbar optic neuritis (HP:0100654) | 4.00102050 |
| 5 | Optic neuritis (HP:0100653) | 4.00102050 |
| 6 | T lymphocytopenia (HP:0005403) | 3.76406911 |
| 7 | Abnormality of T cell number (HP:0011839) | 3.73731917 |
| 8 | Stomatitis (HP:0010280) | 3.72998686 |
| 9 | Increased IgM level (HP:0003496) | 3.70928078 |
| 10 | IgG deficiency (HP:0004315) | 3.66292775 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.48799066 |
| 12 | Recurrent fungal infections (HP:0002841) | 3.43971739 |
| 13 | Eczematoid dermatitis (HP:0000976) | 3.42974127 |
| 14 | Pulmonary infiltrates (HP:0002113) | 3.35699424 |
| 15 | Vasculitis (HP:0002633) | 3.31453583 |
| 16 | Encephalitis (HP:0002383) | 3.25310378 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.24123891 |
| 18 | Abnormality of T cells (HP:0002843) | 3.16623293 |
| 19 | Recurrent cutaneous fungal infections (HP:0011370) | 3.13482578 |
| 20 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.13482578 |
| 21 | Meningitis (HP:0001287) | 3.11926411 |
| 22 | Pustule (HP:0200039) | 3.10262246 |
| 23 | Recurrent abscess formation (HP:0002722) | 3.09928364 |
| 24 | Gastrointestinal infarctions (HP:0005244) | 3.07224798 |
| 25 | Chronic diarrhea (HP:0002028) | 3.04989108 |
| 26 | Mediastinal lymphadenopathy (HP:0100721) | 3.04936851 |
| 27 | Recurrent bacterial skin infections (HP:0005406) | 3.03742685 |
| 28 | Recurrent viral infections (HP:0004429) | 2.95879673 |
| 29 | Abnormality of B cell number (HP:0010975) | 2.91730512 |
| 30 | Panhypogammaglobulinemia (HP:0003139) | 2.90863958 |
| 31 | Systemic lupus erythematosus (HP:0002725) | 2.87530712 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81108236 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81108236 |
| 34 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81108236 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 2.80529740 |
| 36 | Recurrent bronchitis (HP:0002837) | 2.78111081 |
| 37 | Hemoptysis (HP:0002105) | 2.78072160 |
| 38 | Inflammation of the large intestine (HP:0002037) | 2.72864954 |
| 39 | Abnormality of T cell physiology (HP:0011840) | 2.72444817 |
| 40 | Keratoconjunctivitis (HP:0001096) | 2.71110782 |
| 41 | Recurrent skin infections (HP:0001581) | 2.65231910 |
| 42 | Nasal polyposis (HP:0100582) | 2.61177792 |
| 43 | Agammaglobulinemia (HP:0004432) | 2.60544473 |
| 44 | Autoimmune thrombocytopenia (HP:0001973) | 2.59751667 |
| 45 | Hypergammaglobulinemia (HP:0010702) | 2.59387889 |
| 46 | Colitis (HP:0002583) | 2.58791569 |
| 47 | Amyloidosis (HP:0011034) | 2.57063548 |
| 48 | Granulocytopenia (HP:0001913) | 2.56045142 |
| 49 | Gastrointestinal inflammation (HP:0004386) | 2.52636636 |
| 50 | Autoimmune hemolytic anemia (HP:0001890) | 2.50924520 |
| 51 | Severe combined immunodeficiency (HP:0004430) | 2.50760249 |
| 52 | Abnormality of the pleura (HP:0002103) | 2.49933835 |
| 53 | Abnormality of the nasal mucosa (HP:0000433) | 2.49036792 |
| 54 | Chronic otitis media (HP:0000389) | 2.48831413 |
| 55 | Vacuolated lymphocytes (HP:0001922) | 2.48315438 |
| 56 | B lymphocytopenia (HP:0010976) | 2.45441036 |
| 57 | Eosinophilia (HP:0001880) | 2.45185368 |
| 58 | Obstructive lung disease (HP:0006536) | 2.44504646 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.44504646 |
| 60 | Chest pain (HP:0100749) | 2.43810747 |
| 61 | Joint swelling (HP:0001386) | 2.43369602 |
| 62 | Increased IgE level (HP:0003212) | 2.42340222 |
| 63 | Gangrene (HP:0100758) | 2.40843235 |
| 64 | Dysostosis multiplex (HP:0000943) | 2.40439946 |
| 65 | Abnormality of eosinophils (HP:0001879) | 2.40261560 |
| 66 | Leukocytosis (HP:0001974) | 2.36586166 |
| 67 | Anorexia (HP:0002039) | 2.35785723 |
| 68 | Urticaria (HP:0001025) | 2.32622889 |
| 69 | IgA deficiency (HP:0002720) | 2.31452023 |
| 70 | Petechiae (HP:0000967) | 2.30701699 |
| 71 | IgM deficiency (HP:0002850) | 2.26979686 |
| 72 | Increased serum ferritin (HP:0003281) | 2.26120640 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.24603118 |
| 74 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.21713711 |
| 75 | Glomerulopathy (HP:0100820) | 2.18618530 |
| 76 | Polyneuropathy (HP:0001271) | 2.16947847 |
| 77 | Hepatosplenomegaly (HP:0001433) | 2.16286151 |
| 78 | Skin rash (HP:0000988) | 2.16114325 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14447610 |
| 80 | Premature loss of primary teeth (HP:0006323) | 2.11208887 |
| 81 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.07189016 |
| 82 | Arterial thrombosis (HP:0004420) | 2.06086323 |
| 83 | Abnormality of the pericardium (HP:0001697) | 2.02821274 |
| 84 | Pancreatitis (HP:0001733) | 2.01897775 |
| 85 | Gastrointestinal stroma tumor (HP:0100723) | 2.01660696 |
| 86 | Combined immunodeficiency (HP:0005387) | 2.01100139 |
| 87 | Arthralgia (HP:0002829) | 2.00103606 |
| 88 | Abnormality of iron homeostasis (HP:0011031) | 1.98643605 |
| 89 | Epistaxis (HP:0000421) | 1.96114398 |
| 90 | Pulmonary embolism (HP:0002204) | 1.93770717 |
| 91 | Hypochromic anemia (HP:0001931) | 1.89719947 |
| 92 | Loss of speech (HP:0002371) | 1.89584735 |
| 93 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.88800886 |
| 94 | Lymphopenia (HP:0001888) | 1.88563963 |
| 95 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88206502 |
| 96 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88206502 |
| 97 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88206502 |
| 98 | Abnormality of the prostate (HP:0008775) | 1.87615841 |
| 99 | Pulmonary fibrosis (HP:0002206) | 1.87453211 |
| 100 | Purpura (HP:0000979) | 1.86644597 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 3.61331076 |
| 2 | MAP4K1 | 3.39775101 |
| 3 | ERN1 | 3.28746188 |
| 4 | TESK2 | 3.04563243 |
| 5 | RIPK4 | 2.84837615 |
| 6 | MAP3K14 | 2.68336250 |
| 7 | TYK2 | 2.53499635 |
| 8 | TBK1 | 2.49128731 |
| 9 | NME2 | 2.42311192 |
| 10 | TESK1 | 2.19854693 |
| 11 | IKBKE | 2.17767756 |
| 12 | VRK2 | 2.15007323 |
| 13 | IRAK3 | 2.11877625 |
| 14 | TAOK3 | 2.04594970 |
| 15 | IKBKB | 2.03359131 |
| 16 | FES | 1.85621437 |
| 17 | TLK1 | 1.83063494 |
| 18 | JAK1 | 1.75090467 |
| 19 | EPHA2 | 1.72255899 |
| 20 | GRK6 | 1.67503641 |
| 21 | JAK3 | 1.67415702 |
| 22 | IRAK4 | 1.66449328 |
| 23 | HIPK2 | 1.63861432 |
| 24 | CSK | 1.59783135 |
| 25 | KIT | 1.59548438 |
| 26 | ACVR1B | 1.51571076 |
| 27 | ZAP70 | 1.44848953 |
| 28 | PIM2 | 1.34736692 |
| 29 | BTK | 1.31957093 |
| 30 | GRK7 | 1.29059387 |
| 31 | MATK | 1.28301534 |
| 32 | BLK | 1.27736161 |
| 33 | ITK | 1.26752617 |
| 34 | MST1R | 1.26377424 |
| 35 | SYK | 1.25494609 |
| 36 | BCKDK | 1.24301655 |
| 37 | TEC | 1.21879289 |
| 38 | PRPF4B | 1.19638937 |
| 39 | TAOK2 | 1.19386641 |
| 40 | KDR | 1.18459691 |
| 41 | BMPR2 | 1.16310165 |
| 42 | MAP3K11 | 1.11602162 |
| 43 | MAP3K3 | 1.11019043 |
| 44 | EPHB1 | 1.08236834 |
| 45 | ADRBK2 | 1.07459148 |
| 46 | LCK | 1.06503763 |
| 47 | LYN | 1.00241795 |
| 48 | NME1 | 0.99935332 |
| 49 | CSF1R | 0.99537958 |
| 50 | TIE1 | 0.98844840 |
| 51 | MAPKAPK3 | 0.97735159 |
| 52 | MST4 | 0.96066453 |
| 53 | PRKCQ | 0.92958733 |
| 54 | HCK | 0.92559073 |
| 55 | SIK3 | 0.92231914 |
| 56 | ARAF | 0.91833583 |
| 57 | MAP2K6 | 0.91690178 |
| 58 | LIMK1 | 0.91434866 |
| 59 | PTK2B | 0.88880711 |
| 60 | MARK3 | 0.84792584 |
| 61 | MAP2K2 | 0.81746711 |
| 62 | DAPK1 | 0.80886255 |
| 63 | STK10 | 0.80310929 |
| 64 | TGFBR2 | 0.79869347 |
| 65 | MAP2K3 | 0.78294838 |
| 66 | DAPK2 | 0.73847751 |
| 67 | CHUK | 0.69554939 |
| 68 | MAP3K13 | 0.68885933 |
| 69 | JAK2 | 0.67507489 |
| 70 | FGFR4 | 0.61695418 |
| 71 | VRK1 | 0.59797551 |
| 72 | MAPK11 | 0.59429934 |
| 73 | TAOK1 | 0.57239466 |
| 74 | NUAK1 | 0.55779985 |
| 75 | EPHA3 | 0.53748236 |
| 76 | PTK6 | 0.51486587 |
| 77 | CDC42BPA | 0.50775175 |
| 78 | IRAK1 | 0.49494184 |
| 79 | PIM1 | 0.48806835 |
| 80 | LMTK2 | 0.48614172 |
| 81 | GRK1 | 0.47761985 |
| 82 | TNK2 | 0.46972893 |
| 83 | SMG1 | 0.46110330 |
| 84 | SIK2 | 0.45585185 |
| 85 | MAPK7 | 0.45460668 |
| 86 | PDK1 | 0.44261037 |
| 87 | PRKG2 | 0.43333658 |
| 88 | RIPK1 | 0.43250500 |
| 89 | FGR | 0.42938296 |
| 90 | MAPKAPK2 | 0.42251964 |
| 91 | MAP3K1 | 0.40745043 |
| 92 | SCYL2 | 0.38745770 |
| 93 | MOS | 0.36196839 |
| 94 | ABL2 | 0.35413819 |
| 95 | CDK4 | 0.32493160 |
| 96 | FYN | 0.30035890 |
| 97 | PDPK1 | 0.28929645 |
| 98 | ABL1 | 0.28628166 |
| 99 | BMX | 0.28351439 |
| 100 | ZAK | 0.27971496 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.02624101 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.72239861 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 3.65633517 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.43743398 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.27750790 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.20315079 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.94613185 |
| 8 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.85206843 |
| 9 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.81610555 |
| 10 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.47444952 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.40988958 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 2.27585733 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.19463796 |
| 14 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.01327637 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.99477460 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.98459831 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.86614382 |
| 18 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.69167520 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.67968498 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62184737 |
| 21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59961008 |
| 22 | Measles_Homo sapiens_hsa05162 | 1.58234708 |
| 23 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.58055312 |
| 24 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.55953234 |
| 25 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53056442 |
| 26 | Tuberculosis_Homo sapiens_hsa05152 | 1.44807274 |
| 27 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39371206 |
| 28 | Influenza A_Homo sapiens_hsa05164 | 1.35360324 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.34154412 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.31489520 |
| 31 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.26489667 |
| 32 | Malaria_Homo sapiens_hsa05144 | 1.24075216 |
| 33 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.19893766 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.19864312 |
| 35 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.17292910 |
| 36 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.13736991 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.08584448 |
| 38 | Lysosome_Homo sapiens_hsa04142 | 1.07784481 |
| 39 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.03405824 |
| 40 | Proteasome_Homo sapiens_hsa03050 | 1.03006121 |
| 41 | Legionellosis_Homo sapiens_hsa05134 | 1.01480578 |
| 42 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.94819604 |
| 43 | Hepatitis C_Homo sapiens_hsa05160 | 0.93335117 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.92653894 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.86721778 |
| 46 | Shigellosis_Homo sapiens_hsa05131 | 0.83670762 |
| 47 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81078616 |
| 48 | Apoptosis_Homo sapiens_hsa04210 | 0.79639880 |
| 49 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.77961252 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77488787 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.75575651 |
| 52 | Galactose metabolism_Homo sapiens_hsa00052 | 0.74683266 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.71913415 |
| 54 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70372328 |
| 55 | Mineral absorption_Homo sapiens_hsa04978 | 0.68177259 |
| 56 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.67196983 |
| 57 | Salmonella infection_Homo sapiens_hsa05132 | 0.66958760 |
| 58 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.65898980 |
| 59 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.64866830 |
| 60 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.60799040 |
| 61 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59044204 |
| 62 | Hepatitis B_Homo sapiens_hsa05161 | 0.57186115 |
| 63 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.54208438 |
| 64 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.49152747 |
| 65 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.48590582 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48258043 |
| 67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46697120 |
| 68 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.46066976 |
| 69 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45809490 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.45366883 |
| 71 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.44699485 |
| 72 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.44212276 |
| 73 | HTLV-I infection_Homo sapiens_hsa05166 | 0.42764669 |
| 74 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.42066604 |
| 75 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.40273572 |
| 76 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.39190927 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.37106065 |
| 78 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.36830036 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36724830 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.35170761 |
| 81 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.33891233 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.33437818 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.33281266 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32298058 |
| 85 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29212549 |
| 86 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.27556690 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.27073311 |
| 88 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26286707 |
| 89 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.26048188 |
| 90 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.24054152 |
| 91 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22352625 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.22345056 |
| 93 | Salivary secretion_Homo sapiens_hsa04970 | 0.21859913 |
| 94 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.21564072 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.19357736 |
| 96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.18124326 |
| 97 | Platelet activation_Homo sapiens_hsa04611 | 0.15754728 |
| 98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.14305472 |
| 99 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.13259689 |
| 100 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.12747730 |

